Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia 1Febrile Neutropenia 1Aspergillosis 1

Interventions

posaconazole 1liposomal amphotericin B 1Voriconazole 1Micafungin 1Fluconazole 1Blood Specimen Collection 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Aspergillosis × Micafungin × Clear all
NCT01207128 2012-04-20

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

University of Arkansas

Phase 2 Withdrawn

Aspergillosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡